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The main inhibitory neurotransmitter, GABA, acts on both ligand-gated and G protein-
coupled receptors, the GABAA/C and GABAB receptors, respectively. The later play
important roles in modulating many synapses, both at the pre- and post-synaptic levels,
and are then still considered as interesting targets to treat a number of brain diseases,
including addiction. For many years, several subtypes of GABAB receptors were expected,
but cloning revealed only two genes thatwork in concert to generate a single type of GABAB
receptor composed of two subunits. Here we will show that the signaling complexity of
this unit receptor type can be largely increased through various ways, including receptor
stoichiometry, subunit isoforms, cell-surface expression and localization, crosstalk with
other receptors, or interacting proteins. These recent data revealed how complexity of a
receptor unit can be increased, observation that certainly are not unique to the GABAB
receptor.
Keywords: GABAB receptor, dimers, large oligomers, G-protein coupled receptor interacting proteins, signal
transduction
INTRODUCTION
Neurons communicate with others to form network in the
brain through the release and detection of neurotransmitters.
Many receptors participate in the detection of neurotransmitters
including ionotropic receptors which mediate fast responses and
metabotropic receptors which induce slow and long-term plas-
ticity regulations. Metabotropic glutamate receptors (mGluRs),
which are activated by glutamate, the major excitatory neu-
rotransmitter of the central nervous system (CNS), consist of
eight subtypes named from mGluR1 to mGluR8 show differ-
ent localization and signaling in synapse (Kniazeff et al., 2011).
Other receptors such as serotonin receptors and dopamine
receptors, which are activated by serotonin or dopamine, also
have several variants (Lee et al., 2000). However, as the main
inhibitory neurotransmitter in the CNS, gamma aminobutyric
acid (GABA) has only one metabotropic receptor subtype, GABAB
receptor (Kaupmann et al., 1998; Benke et al., 1999; Marshall
et al., 1999). Located both pre-synaptically and post-synaptically,
GABAB receptor is thought to play a role in CNS disorders
such as epilepsy, spasticity, schizophrenia, anxiety, depression,
cognitive deﬁcits, and addiction (Bettler et al., 2004). It is also
shown to be involved in cell survival, nerve growth cone guid-
ance, migration and position of neurons (Xiang et al., 2002;
McClellan et al., 2008; Zhou et al., 2008). How one GABAB
receptor induces multiple downstream functions remains to
be discussed. Here, we show how multiple functions can be
generated from a single GABAB receptor through: (1) the
oligomeric state in dimers or larger complexes; (2) subunit and
isoform variants; (3) cell surface expression and localization;
(4) crosstalk with other receptors GABAB receptor interacting
proteins.
DIMERIZATION AND LARGE OLIGOMIZATION OF GABAB
RECEPTOR
As a member of GPCR class C, GABAB receptor consists of
two subunits: GABAB1 and GABAB2, and functions as a het-
erodimer (Kaupmann et al., 1998; Marshall et al., 1999). As shown
in Figure 1, each subunit is composed of a large extracellular
domain (Venus ﬂytrap, VFT), a seven-transmembrane domain,
and an intracellular C-terminal. Although GABAB2 shares 54%
similarity with GABAB1, only the VFT domain of GABAB1 can
bind ligands (such as GABA and baclofen) and orthosteric antag-
onists (such as CGP54626, CGP64213; Pin et al., 2004; Geng
et al., 2012; Geng et al., 2013). Due to the presence of endoplas-
mic reticulum (ER) retention sequence (RSRR) in the C-terminal,
GABAB1 cannot reach the plasma membrane by itself. GABAB2
masks GABAB1 ER retention sequence via a coiled-coil domain to
escort GABAB1 to the cell surface (Galvez et al., 2001). GABAB2
ectodomain does not bind GABA, but interacts with the GABAB1
ectodomain to increase agonist afﬁnity by stabilizing the agonist-
bound conformation of GABAB1(Liu et al., 2004; Rondard et al.,
2008; Geng et al., 2012). GABAB2 is also responsible for G protein
coupling (Duthey et al., 2002; Havlickova et al., 2002). Following
activationof Gi/o protein,Gαi/o subunits inhibit adenylyl cyclase to
reduce cAMP levels while Gβγ subunits inhibit Ca2+ channels and
activate K+ channels (Bowery et al., 2002; Ulrich and Bettler, 2007;
Chalifoux and Carter, 2011).
Up to now, baclofen is the only drug targeting GABAB recep-
tor in the market, which is used as a muscle relaxant to treat
spasticity (Froestl, 2010). Positive allosteric modulators (PAMs),
such as CGP7930 and GS39783, bind within GABAB2 trans-
membrane domain to strengthen the effect of agonists (Urwyler
et al., 2001). CGP7930 acts as a PAM and partial agonist through
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FIGURE 1 | Structure organization of GABAB receptor. GABAB receptor
forms heterodimer composed by GABAB1 and GABAB2. GABAB1 is
responsible for ligand binding in N-terminal VFT domain, whereas the VFT
of GABAB2 fails to bind any known ligand. PAMs bind to GABAB2
transmembrane domain to potentiate the effect of agonist.
GABAB2 which can facilitate agonist response at low concen-
tration and activate the receptor alone at higher concentra-
tion (Urwyler et al., 2001; Onali et al., 2003; Binet et al., 2004;
Tu et al., 2007).
Dimers, tetramers, or higher order oligomers of GABAB
receptor can be detected both in heterologous system
(Maurel et al., 2008; Calebiro et al., 2013) and in native neu-
rons (Schwenk et al., 2010; Comps-Agrar et al., 2011). GABAB
receptor is present in equilibrium between heterodimers and
higher-order oligomers, with a relative preference for tetramers
(dimers of dimers) and octamers (tetramers of dimers; Calebiro
et al., 2013). Whereas GABAB receptor heterodimers are sta-
ble due to strong non-covalent interactions, the higher-order
oligomers are the result of weaker and likely transient interactions
among heterodimers (Calebiro et al., 2013). Although agonist
stimulation did not alter receptor di-/oligomerization (Calebiro
et al., 2013), destabilizing the oligomers by a competitor or a
GABAB1 mutant revealed different G protein coupling efﬁciencies
depending on the oligomeric state of the receptor (Comps-
Agrar et al., 2012), suggesting a negative functional cooperativity
between the GABAB receptor heterodimers within the large
oligomers.
GABAB RECEPTOR SUBUNITS AND ISOFORMS
The GABAB receptor subunits GABAB1 and GABAB2 are co-
expressed throughout the brain (Bettler et al., 2004; Lujan et al.,
2004; Bettler and Tiao, 2006). GABAB1 knock-out mice displayed
seizures, hyperalgesia, hyperlocomotion, memory impairment,
anxiety, and immobility decrease (Schuler et al., 2001; Rutti-
mann et al., 2004; Catalano et al., 2005) while inactivation of the
GABAB2 induced similar phenotype (Mombereau et al., 2005).
Both the GABAB1 and GABAB2 subunits are essential for nor-
mal function of GABAB receptor. However, baclofen was able to
inhibit K+ channels in theCA1pyramidal neurons of GABAB2−/−
mice (Gassmann et al., 2004), suggesting speciﬁc properties of
GABAB1 in the absence of GABAB2. Mutation of the GABAB1
ER retention sequence RSRR to ASAR allows GABAB1 to reach
the cell surface by itself (Couve et al., 1998). GABAB receptor
agonist, baclofen, could induce ERK phosphorylation in cere-
bellar granule cells and HEK cells overexpressed GABAB1 and
GABAB2 (Tu et al., 2007). The GABAB1-ASAR mutant could
also increase ERK phosphorylation through Gβγ in the absence
of GABAB2 (Baloucoune et al., 2012). Although only GABAB2
was reported to be important for Gi/o coupling, Gβγ were
found to pre-couple to C-terminal of GABAB for presynap-
tic inhibition (Laviv et al., 2011). These observations suggested
the direct coupling from GABAB1 to G protein signaling. On
the other hand, GABAB2 alone co-precipitated and co-expressed
with M2 muscarinic receptor (M2R) in cortical neurons. Co-
expression of the GABAB2 rescued internalization of M2R and
desensitization of GIRK channels induced by chronic stimula-
tion (Boyer et al., 2009). Since GABAB1 and GABAB2 do not
always exhibit the same expression pattern (Bettler and Tiao,
2006), the interaction between M2R and the GABAB2 provides
a possible mechanism for signaling induced by GABAB2 alone.
Overall, though it is well accepted GABAB1 and GABAB2 form a
functional receptor together, it is still possible that each subunit
plays individual roles, no matter when they act in heterodimer or
alone.
Furthermore, 14 isoforms of the GABAB1 can be generated
by differential transcription or splicing of the mRNA named
from GABAB1a to GABAB1n (Bettler et al., 2004). GABAB1a
and GABAB1b are the most abundant isoforms expressed in
brain (Benke et al., 1999). GABAB1c has a single sushi-domain
and widely expressed in brain and form functional receptors
in HEK cells co-expressed with GABAB2 (Pfaff et al., 1999).
GABAB1e/g/h/i/j/l/m/n do not have transmembrane domains.
Been secreted, GABAB1e strongly interacted with GABAB2 and
disturbed normal GABAB1/GABAB2 association, but failed to
disrupt G-protein coupled inwardly rectifying potassium activa-
tion (Schwarz et al., 2000). Puriﬁed sushi domains of GABAB1j
could impair the inhibitory effect of GABAB heteroreceptors on
evoked and spontaneous glutamate release (Tiao et al., 2008).
GABAB1g/h/i show similar sequence with GABAB1j containing
the sushi domains followed by a unique C-terminal sequence
(Jiang et al., 2012), but the function remains to be detected.
The inhibitory effect of GABAB heteroreceptors-induced potas-
sium current was also found in GABAB1l and GABAB1m, but not
for GABAB1k (Lee et al., 2010). Other isoforms like GABAB1d/f
were mostly detected in transcription expression proﬁle and no
function was conﬁrmed yet (Jiang et al., 2012). GABAB1a and
GABAB1b are well studied compared with others. GABAB1a has
two additional sushi domains in the N-terminal region, com-
pared with GABAB1b (Blein et al., 2004). Due to the presence
of these sushi domains, GABAB1a preferentially targets to the
axon terminals of excitatory synapses. Post-synaptically, both
isoforms were found in dendrites, but only GABAB1b could local-
ize in spine heads (Vigot et al., 2006; Biermann et al., 2010).
GABAB1b was responsible for mediating postsynaptic inhibi-
tion of Ca2+ spikes, whereas presynaptic inhibition of GABA
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release was mediated by GABAB1a (Perez-Garci et al., 2006).
GABAB1a, but not GABAB1b, was involved in impaired synap-
tic plasticity in hippocampus long-term potentiation (Vigot
et al., 2006), emphasizing the molecular differences in synap-
tic GABAB functions. GABAB1a and GABAB1b also contributed
differentially to GABAB receptor-mediated cognitive processes
such as spontaneous alternation, object recognition and passive
avoidance (Jacobson et al., 2007). Till now, no difference has
been shown on molecular pharmacology between GABAB1a and
GABAB1b (Billinton et al., 2001). However, CHOP was found
to subtype-selective interact with GABAB1a but not GABAB1b
and reduced GABAB1a/GABAB2 receptor cell surface expression
(Sauter et al., 2005), suggesting the functional diversity medi-
ated by GABAB1a and GABAB1b through different protein-protein
interactions.
GABAB RECEPTOR CELL SURFACE EXPRESSION AND
LOCALIZATION
Control of cell surfaceGABAB receptor expression plays an impor-
tant role in the regulation of receptor efﬁcacy. GABAB receptor cell
surface expression is remarkably stable and baclofen treatment did
not elicit conventional β-arrestin recruitment (Couve et al., 2002;
Fairfax et al., 2004). However, GABAB receptor undergoes rapid
constitutive receptor internalization (Grampp et al., 2007). The
balance between sorting and degradation after internalization and
rapid recycling process maintains its cell surface expression sta-
bility (Grampp et al., 2008). Phosphorylation of serine892 in the
C-terminus of GABAB2 is important for cell surface expression sta-
bility. Chronic agonist stimulation de-phosphorylates serine892
in GABAB2 and decreases GABAB receptor cell surface expression
(Couve et al., 2002; Fairfax et al., 2004). The interaction between
endogenous proteinMupp1 andGABAB2 also plays a role tomain-
tain GABAB receptor membrane stability (Balasubramanian et al.,
2007).
Lipid rafts are specializedmicrodomains compartmentalize cel-
lular processes by serving as organizing centers for the assembly of
signaling molecules to regulate signal transduction. The GABAB
receptor and its downstream effectors, Gαi and Gαo proteins, are
all localized in lipid rafts (Becher et al., 2001, 2004). Interestingly,
GABAB receptors exhibited a lower GTPγS response to ago-
nist binding in raft-enriched fractions than in whole membranes
(Becher et al., 2004), suggesting that changes in membrane envi-
ronment may regulate its function. Activation of 5-HT1a receptor
could target it to lipid rafts and facilitated receptor-mediated signal
transduction (Renner et al., 2007), whereas mu-opioid recep-
tor agonists promoted receptor exiting from lipid rafts (Zheng
et al., 2008). Examination of the dynamic lateral diffusion of
GABAB receptors at the cell surface revealed restricted mobility
of GABAB2. After activation by baclofen, levels of the mobile
fraction were signiﬁcantly increased (Pooler and McIlhinney,
2007). Furthermore, by using single-molecule analysis of ﬂuo-
rescently labeled GPCR revealed that larger oligomers of GABAB
receptor were prevalently organized into ordered arrays (Calebiro
et al., 2013). Agonist stimulation increased the mobility of large
oligomer of GABAB receptor on the cell surface (Calebiro et al.,
2013). These data suggested the possibility of GABAB recep-
tor mobility between lipid raft and non-lipid raft domains.
Given that the level of cell surface GABAB receptors is highly
stable following activation, lateral diffusion of GABAB recep-
tor might provide another mechanism for controlling its signal
strength.
CROSSTALK OF GABAB RECEPTOR WITH OTHER RECEPTORS
GABAB AND GABAA RECEPTORS
Both receptors are located pre-synaptically and post-synaptically.
GABAA receptors are Cl− ion channels which produce fast
electrical signals, whereas GABAB receptor induced long-term
modulation through G protein-regulated gene transcription and
protein synthesis (Luscher et al., 2011). Crosstalk between them
was identiﬁed in several cell types. Due to variants of GABAA
receptor subtype in different neurons, GABAB receptor showed
multiple functions. In developing hypothalamic neurons, GABAB
receptor activation can depress GABAA receptor-mediated Ca2+
rise by both reducing the synaptic release of GABA presy-
naptically and decreasing the postsynaptic Ca2+ responsiveness
(Obrietan and van den Pol, 1998). In dentate gyrus gran-
ule cells, GABAB receptors showed remarkable distribution
overlap with GABAA receptor on post-synaptic dendritic and
somatic membranes. GABAB receptors enhanced tonic inhibi-
tion induced by extrasynaptic GABAA receptor (Tao et al., 2013).
This was also observed in ventrobasal thalamus and cerebel-
lar granule cells, but absent in CA1 pyramidal cells or layer
2/3 cortical pyramidal neurons (Connelly et al., 2013; Tao et al.,
2013). One explanation is that postsynaptic GABAB receptor
is possible to preferentially modulate δ–type subunit containing
GABAA receptor which is dominant in dentate gyrus gran-
ule cells, compared with α5–type subunit containing GABAA
receptor, which is expressed in CA1 pyramidal cells (Caraiscos
et al., 2004; Glykys et al., 2008). The γ2 subunit of GABAA was
found to interact with GABAB receptors and regulate GABAB
receptor internalization (Balasubramanian et al., 2004). On the
other hand, activation of GABAB receptor promotes GABAA
receptor cell surface expression through increasing secreting
brain-derived neurotrophic factor (BDNF) and PLC/DAG/PKC
activation (Kuczewski et al., 2011). The crosstalk between GABAB
and GABAA receptors shows possibility for drug co-application
in disease treatment. In animal model, co-application of both
of their agonists: muscimol and baclofen protected hippocam-
pal CA1 neurons in cerebral ischemic injury (Zhang et al.,
2007). Tiagabine and vigabatrin which increase GABA level in
the brain and affect both GABAB and GABAA receptor activ-
ity, are effective in treating alcohol addiction (Tyacke et al.,
2010).
GABAB RECEPTORS AND mGluR1s
Metabotropic glutamate receptors 1 also belongs to GPCR class
C as GABAB receptor. It is coupled to Gq protein to increase
IP3 production and Ca2+ ﬂux when activated by glutamate
(Mao et al., 2005). Both receptors exhibited a high co-localization
in the dendritic spine of Purkinje cells (Kamikubo et al., 2007;
Rives et al., 2009) and co-immunoprecipitated from brain lysates
(Tabata et al., 2004), but no oligomerization of GABAB recep-
tor and mGluR1a was observed (Rives et al., 2009), suggesting
the existence of a GABAB-mGluR1 receptor complex but no
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direct physical contact. GABAB receptor enhanced the long-
term depression of a glutamate-evoked current and increased the
magnitude of depression in cerebellar parallel ﬁber–Purkinje cell
synapses (Kamikubo et al., 2007). PLC, Gαi/o and Gβγ subunits
was involved in GABAB receptor potentiated mGluR1 signaling
(Rives et al., 2009). Baclofen regulated mGluR1-current was con-
centration dependent: a low concentration of baclofen showed
augment effect while higher concentration showed inhibition
(Hirono et al., 2001). The crosstalk was also related to mGluR1a
receptor expression: more potentiation by GABAB receptor when
mGluR1a receptors were less expressed (Rives et al., 2009). It
suggests a precise control of two receptors for the balance of
neuronal inhibition and activation. The crosstalk between Gi/o-
coupled and Gq-coupled receptors which is independent of
direct interaction was also observed in other receptors such as
mGluR1a and mGluR2 or GABAB and 5-HT2c receptor (Rives
et al., 2009). The co-compartmentalization of these receptors
and other scaffold proteins like G proteins, homer to assem-
ble in platforms ensures the crosstalk speciﬁcity (Bockaert et al.,
2004).
GABAB AND NMDA RECEPTORS
Gamma aminobutyric acid(B) receptor cell surface expression
is independent of agonist stimulation but controlled by gluta-
mate. Application of glutamate, mainly through NMDA receptor,
decreased GABAB receptor cell surface expression and GABAB
receptor activated K+ channel current (Guetg et al., 2010; Maier
et al., 2010; Terunuma et al., 2010). Activated by NMDA receptors,
CaMKII can directly interact with and phosphorylates serine867
in the C-terminus of GABAB1 to trigger GABAB receptor endocy-
tosis (Guetg et al., 2010). CaMKII might be a key signal molecular
to modulate the crosstalk between GABAB receptor signaling and
glutamate signaling as CaMKII was shown to interact with the
NMDA receptor and regulate NMDA receptor controlled plastic-
ity (Bayer et al., 2001; El Gaamouch et al., 2012). Upon NMDA
receptor activation, the phosphorylation of serine783 in GABAB2
was increased by AMP-dependent protein kinase (Terunuma
et al., 2010). Furthermore, both presynaptic and postsynaptic
GABAB receptor can regulate NMDA-mediated excitatory cur-
rents (Morrisett et al., 1991; Sun et al., 2006). Baclofen improved
NMDA hypofunction-related social function and spatial memory
deﬁcient in knockout mice model (Gandal et al., 2012), suggest-
ing the crosstalk between GABAB and NMDA receptors in two
directions.
GABAB AND TYROSINE KINASE RECEPTORS
The transactivation of GPCR to RTK is an important signaling
pathway which contributes to growth promotion activity (Del-
court et al., 2007). GABAB receptor could trigger secretion of
BDNF and subsequent activation of the BDNF-related kinase
TrkB receptor signaling pathway to promote the development of
GABAergic synapses which is called ligand-dependent transactiva-
tion (Fiorentino et al., 2009). GABAB receptor could transactivate
insulin-like growth factor-1 (IGF-1) receptor to induce Akt phos-
phorylation and protect cerebellar granule cells from apoptosis.
This was independent of ligand IGF-1 (Tu et al., 2010). The ﬁrst
mechanism leads to the RTK activation in cells surrounding the
activatedGPCRdue to adiffusionof the ligand,whereas the second
mechanism is mediated by intracellular event that is limited to the
signaling protein complex dynamically regulated upon receptor
activation. Gi/o proteins were found to be pre-associated with the
GABAB receptor. Upon activation, the Gαi/o and Gβγ subunits
were released from GABAB receptor, followed by recruitment of
FAK1, IGF-1 receptor, and Akt to GABAB receptor. FAK1 played
a key role in coordinating this dynamic process. This dynamic
of the GABAB receptor-associated complex is critical for signal-
ing transduction and transactivation-dependent neuronal survival
(Lin et al., 2012). Other RTKs such as epidermal growth factor
receptor, neurotrophin receptor, platelet derived growth factor
receptor, and ﬁbroblast growth factor receptor have been investi-
gated for other GPCRs (Peavy et al., 2001; Shah and Catt, 2004).
Whether GABAB receptor transactivates other RTKs remains to be
identiﬁed.
GABAB RECEPTOR INTERACTING PROTEINS
The intracellularGABAB receptor interacting proteins are involved
in GABAB receptor functions such as cell surface expression
(e.g., CHOP, MUPP1) (Sauter et al., 2005; Balasubramanian
et al., 2007), desensitization (e.g., GRK4, NSF) (Perroy et al.,
2003; Pontier et al., 2006) and signaling transduction (e.g.,
G proteins, ATF4, FAK1) (Vernon et al., 2001; Lin et al., 2012).
Several new proteins have been identiﬁed recently to modu-
late GABAB receptor heterodimer function. 14-3-3ζ interacting
with GABAB1 coiled-coil domain can partially bind to GABAB1
coiled-coil domain and disrupt association of GABAB1/GABAB2
heterodimers (Couve et al., 2001). Disruption of 14-3-3ζ/GABAB1
interaction provides a strategy to enhance the effect of antinoci-
ceptive drugs (Laffray et al., 2012). The potassium channel
tetramerization domain-containing (KCTD) protein family mem-
bers KCTD8, KCTD12, KCTD12b, and KCTD16 are tightly
associated with the C-terminus of GABAB2 as auxiliary sub-
units in tetramers (Bartoi et al., 2010; Schwenk et al., 2010).
This co-assembly changes the properties of the GABAB1 and
GABAB2 core receptor in a KCTD subtype-speciﬁc manner.
KCTD16 and KCTD8 led to persistent inhibition of Cav chan-
nels activity, whereas KCTD12 and KCTD12b receptors tran-
siently decreased Cav channels activity (Schwenk et al., 2010;
Seddik et al., 2012). Except regulating agonist potency and kinet-
ics, KCTD12 reduced constitutive receptor internalization to
increase the magnitude of receptor signaling (Ivankova et al.,
2013). The expression levels of individual KCTD transcripts
vary during postnatal brain development. KCTD12 and KCTD16
are widely expressed in most neurons whereas KCTD8 and
KCTD12b show a restricted expression pattern (Metz et al., 2011).
The distinct spatial and temporal KCTD distribution patterns
might underlie functional differences in native GABAB receptor
responses.
CONCLUSION
In all, we summarize how one single GABAB receptor generates
multiple functions through the following aspects: (1) the com-
position of tetramer and large oligomer increased the complexity
of the receptor; (2) Variants of subunits and isoforms contribute
to functional diversity. Differential compartmentalization of the
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FIGURE 2 | Schematic presentation of GABAB receptor interacting
proteins and crosstalk of GABAB receptor with other receptors.
GABAB receptor interacting proteins are binding to the C-terminus of
GABAB receptor modulating the receptor membrane expression (e.g.,
CHOP, MUPP1), desensitization (e.g., GRK4, NSF), signaling transduction
(e.g., G proteins, ATF4) and diverse function (e.g., 14-3-3ζ, KCTD8,
KCTD12, KCTD12b, and KCTD16). At the membrane, GABAB receptors
have crosstalk with other receptors such as GABAA receptor, mGluR1,
NMDA receptor, TrkB receptor and IGF-1 receptor. Both heterodimers
and tetramers of GABAB receptors exist at the membrane. Dimers and
dimers of GABAB receptors form tetramers through GABAB1 and
GABAB1 interaction.
receptor variants participate in distinct function; (3) Cell surface
expression and localization in lipid raft are involved in regulat-
ing receptor signaling efﬁcacy; (4) Novel functions are generated
through crosstalk with interacting proteins, auxiliary subunits or
other membrane receptors as shown in Figure 2. The observation
of the complexity generated from a single GPCR such as GABAB
receptor will provide new strategy for drug development.
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